418 related articles for article (PubMed ID: 15470637)
1. Expression and activity of osteoblast-targeted Cre recombinase transgenes in murine skeletal tissues.
Liu F; Woitge HW; Braut A; Kronenberg MS; Lichtler AC; Mina M; Kream BE
Int J Dev Biol; 2004 Sep; 48(7):645-53. PubMed ID: 15470637
[TBL] [Abstract][Full Text] [Related]
2. Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast.
Dacquin R; Starbuck M; Schinke T; Karsenty G
Dev Dyn; 2002 Jun; 224(2):245-51. PubMed ID: 12112477
[TBL] [Abstract][Full Text] [Related]
3. Collagen1alpha1 promoter drives the expression of Cre recombinase in osteoblasts of transgenic mice.
Zha L; Hou N; Wang J; Yang G; Gao Y; Chen L; Yang X
J Genet Genomics; 2008 Sep; 35(9):525-30. PubMed ID: 18804071
[TBL] [Abstract][Full Text] [Related]
4. Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage.
Kalajzic I; Kalajzic Z; Kaliterna M; Gronowicz G; Clark SH; Lichtler AC; Rowe D
J Bone Miner Res; 2002 Jan; 17(1):15-25. PubMed ID: 11771662
[TBL] [Abstract][Full Text] [Related]
5. An efficient system for tissue-specific overexpression of transgenes in podocytes in vivo.
Moeller MJ; Soofi A; Sanden S; Floege J; Kriz W; Holzman LB
Am J Physiol Renal Physiol; 2005 Aug; 289(2):F481-8. PubMed ID: 15784842
[TBL] [Abstract][Full Text] [Related]
6. Odontoblast-specific expression of cre recombinase successfully deletes gene segments flanked by loxP sites in mouse teeth.
Sreenath TL; Cho A; Thyagarajan T; Kulkarni AB
Genesis; 2003 Feb; 35(2):94-9. PubMed ID: 12533791
[TBL] [Abstract][Full Text] [Related]
7. Bone-directed expression of Col1a1 promoter-driven self-inactivating retroviral vector in bone marrow cells and transgenic mice.
Stover ML; Wang CK; McKinstry MB; Kalajzic I; Gronowicz G; Clark SH; Rowe DW; Lichtler AC
Mol Ther; 2001 Apr; 3(4):543-50. PubMed ID: 11319916
[TBL] [Abstract][Full Text] [Related]
8. Beta cell-specific ablation of target gene using Cre-loxP system in transgenic mice.
Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
J Surg Res; 1999 Jun; 84(2):199-203. PubMed ID: 10357920
[TBL] [Abstract][Full Text] [Related]
9. Col1a1-driven transgenic markers of osteoblast lineage progression.
Dacic S; Kalajzic I; Visnjic D; Lichtler AC; Rowe DW
J Bone Miner Res; 2001 Jul; 16(7):1228-36. PubMed ID: 11450698
[TBL] [Abstract][Full Text] [Related]
10. The 3.6 kb DNA fragment from the rat Col1a1 gene promoter drives the expression of genes in both osteoblast and osteoclast lineage cells.
Boban I; Jacquin C; Prior K; Barisic-Dujmovic T; Maye P; Clark SH; Aguila HL
Bone; 2006 Dec; 39(6):1302-12. PubMed ID: 16938497
[TBL] [Abstract][Full Text] [Related]
11. A novel transgenic technique that allows specific marking of the neural crest cell lineage in mice.
Yamauchi Y; Abe K; Mantani A; Hitoshi Y; Suzuki M; Osuzu F; Kuratani S; Yamamura K
Dev Biol; 1999 Aug; 212(1):191-203. PubMed ID: 10419695
[TBL] [Abstract][Full Text] [Related]
12. Rearrangement of a conditional allele regardless of inheritance of a Cre recombinase transgene.
Cochrane RL; Clark SH; Harris A; Kream BE
Genesis; 2007 Jan; 45(1):17-20. PubMed ID: 17211878
[TBL] [Abstract][Full Text] [Related]
13. Neural expression of alpha-internexin promoter in vitro and in vivo.
Wang P; Wang SM; Hsieh CJ; Chien CL
J Cell Biochem; 2006 Feb; 97(2):275-87. PubMed ID: 16173078
[TBL] [Abstract][Full Text] [Related]
14. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo.
Kisanuki YY; Hammer RE; Miyazaki J; Williams SC; Richardson JA; Yanagisawa M
Dev Biol; 2001 Feb; 230(2):230-42. PubMed ID: 11161575
[TBL] [Abstract][Full Text] [Related]
15. A mouse model for beta cell-specific ablation of target gene(s) using the Cre-loxP system.
Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
Biochem Biophys Res Commun; 1998 Dec; 253(1):65-9. PubMed ID: 9875221
[TBL] [Abstract][Full Text] [Related]
16. Megakaryocyte gene targeting mediated by restricted expression of recombinase Cre.
Nowakowski A; Alonso-Martín S; Arias-Salgado EG; Fernández D; Vilar M; Ayuso MS; Parrilla R
Thromb Haemost; 2011 Jan; 105(1):138-44. PubMed ID: 20941460
[TBL] [Abstract][Full Text] [Related]
17. Site- and time-specific gene targeting in the mouse.
Metzger D; Chambon P
Methods; 2001 May; 24(1):71-80. PubMed ID: 11327805
[TBL] [Abstract][Full Text] [Related]
18. A novel technique for temporally regulated cell type-specific Cre expression and recombination in the pituitary gonadotroph.
Naik K; Pittman I; Wolfe A; Miller RS; Radovick S; Wondisford FE
J Mol Endocrinol; 2006 Aug; 37(1):63-9. PubMed ID: 16901924
[TBL] [Abstract][Full Text] [Related]
19. Podocyte-specific expression of cre recombinase in transgenic mice.
Moeller MJ; Sanden SK; Soofi A; Wiggins RC; Holzman LB
Genesis; 2003 Jan; 35(1):39-42. PubMed ID: 12481297
[TBL] [Abstract][Full Text] [Related]
20. Cre recombinase expression controlled by the hematopoietic regulatory domain of Gata-1 is erythroid-specific.
Yoon D; Kim B; Prchal JT
Blood Cells Mol Dis; 2008; 40(3):381-7. PubMed ID: 18077194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
